Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031)

The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine, required for the vaccinations in the National Immunisation Program in Finland. The contract period is one (1) year during 2027 - 2028. The procurement contains three (3) one (1) -year contract period renewals (1 + 1 + 1) to extend the contract for the years 2029, 2030 and 2031. Estimated quantity for the contract period including contract period renewals is 560,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one

319010-2026 Page 4/7 Criterion: Type: Price Description: The cheapest price Category of award fixed criterion: Fixed value (total) Award criterion number: 100

Vaccines